MX2018015506A - Vacuna contra virus de bronquitis infecciosa. - Google Patents
Vacuna contra virus de bronquitis infecciosa.Info
- Publication number
- MX2018015506A MX2018015506A MX2018015506A MX2018015506A MX2018015506A MX 2018015506 A MX2018015506 A MX 2018015506A MX 2018015506 A MX2018015506 A MX 2018015506A MX 2018015506 A MX2018015506 A MX 2018015506A MX 2018015506 A MX2018015506 A MX 2018015506A
- Authority
- MX
- Mexico
- Prior art keywords
- present
- orf
- subject
- infectious bronchitis
- bronchitis virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20061—Methods of inactivation or attenuation
- C12N2770/20062—Methods of inactivation or attenuation by genetic engineering
Abstract
La presente invención se refiere, entre otros, a un IBV (virus de bronquitis infecciosa) y a una composición inmunogénica que comprende un IBV, respectivamente, en donde el ORF 3a y/o el ORF 3b y/o el ORF 5a y/o el ORF 5b está inactivado. Por otra parte, la presente invención se refiere a métodos para inmunizar a un sujeto que comprende la administración a un sujeto de la composición inmunogénica de la presente invención. Más aún, la presente invención se refiere a métodos de tratamiento o de prevención de signos clínicos causados por IBV en un sujeto que lo necesita, que comprende la administración al sujeto de una cantidad terapéuticamente eficaz de una composición inmunogénica de conformidad con la presente invención.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16174857 | 2016-06-16 | ||
PCT/EP2017/064442 WO2017216180A1 (en) | 2016-06-16 | 2017-06-13 | Vaccine against infectious bronchitis virus |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018015506A true MX2018015506A (es) | 2019-05-22 |
Family
ID=56148179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018015506A MX2018015506A (es) | 2016-06-16 | 2017-06-13 | Vacuna contra virus de bronquitis infecciosa. |
Country Status (12)
Country | Link |
---|---|
US (1) | US11065328B2 (es) |
EP (1) | EP3471769A1 (es) |
JP (1) | JP6874023B2 (es) |
KR (1) | KR20190021334A (es) |
CN (1) | CN109641043A (es) |
AR (1) | AR108829A1 (es) |
BR (1) | BR112018076234A2 (es) |
CO (1) | CO2019000214A2 (es) |
EA (1) | EA201990010A1 (es) |
IL (1) | IL263550A (es) |
MX (1) | MX2018015506A (es) |
WO (1) | WO2017216180A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2018015506A (es) | 2016-06-16 | 2019-05-22 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra virus de bronquitis infecciosa. |
EP3873516A1 (en) * | 2018-10-31 | 2021-09-08 | Boehringer Ingelheim Vetmedica GmbH | 4/91 ibv vaccine with heterologous spike protein |
AR116878A1 (es) * | 2018-10-31 | 2021-06-23 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna de ibv h52 con proteína espicular heteróloga |
CN110467671B (zh) * | 2019-07-04 | 2022-08-23 | 中崇信诺生物科技泰州有限公司 | 一种用spf鸡制备tw1型鸡传染性支气管炎病毒阳性血清的方法 |
CN111893212A (zh) * | 2020-06-17 | 2020-11-06 | 安徽农业大学 | 猫传染性腹膜炎病毒实时荧光定量pcr引物组及试剂盒 |
CN112048006B (zh) * | 2020-09-08 | 2021-04-27 | 扬州大学 | 一种替代中和效力测定的elisa方法及其应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
PT1259257E (pt) | 2000-02-29 | 2010-06-01 | Wyeth Llc | Protecção in ovo contra a bronquite infecciosa |
CN102382812A (zh) * | 2010-12-15 | 2012-03-21 | 江苏省家禽科学研究所 | 传染性支气管炎病毒h120疫苗株反向遗传操作系统及其操作方法 |
CN102851257A (zh) * | 2012-08-27 | 2013-01-02 | 上海启盛生物科技有限公司 | 一种鸡传染性支气管炎病毒减毒疫苗株及其应用 |
MX2018015506A (es) | 2016-06-16 | 2019-05-22 | Boehringer Ingelheim Vetmedica Gmbh | Vacuna contra virus de bronquitis infecciosa. |
-
2017
- 2017-06-13 MX MX2018015506A patent/MX2018015506A/es unknown
- 2017-06-13 CN CN201780049633.3A patent/CN109641043A/zh active Pending
- 2017-06-13 BR BR112018076234-2A patent/BR112018076234A2/pt not_active IP Right Cessation
- 2017-06-13 WO PCT/EP2017/064442 patent/WO2017216180A1/en unknown
- 2017-06-13 JP JP2018565802A patent/JP6874023B2/ja active Active
- 2017-06-13 EA EA201990010A patent/EA201990010A1/ru unknown
- 2017-06-13 EP EP17732054.6A patent/EP3471769A1/en not_active Withdrawn
- 2017-06-13 KR KR1020197001422A patent/KR20190021334A/ko not_active Application Discontinuation
- 2017-06-14 US US15/622,672 patent/US11065328B2/en active Active
- 2017-06-15 AR ARP170101649A patent/AR108829A1/es unknown
-
2018
- 2018-12-06 IL IL263550A patent/IL263550A/en unknown
-
2019
- 2019-01-11 CO CONC2019/0000214A patent/CO2019000214A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20190021334A (ko) | 2019-03-05 |
JP6874023B2 (ja) | 2021-05-19 |
IL263550A (en) | 2019-01-31 |
JP2019521987A (ja) | 2019-08-08 |
CO2019000214A2 (es) | 2019-01-18 |
BR112018076234A2 (pt) | 2019-03-26 |
WO2017216180A1 (en) | 2017-12-21 |
US11065328B2 (en) | 2021-07-20 |
EP3471769A1 (en) | 2019-04-24 |
EA201990010A1 (ru) | 2019-07-31 |
US20170360921A1 (en) | 2017-12-21 |
AR108829A1 (es) | 2018-10-03 |
CN109641043A (zh) | 2019-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
MX2018014573A (es) | Vacuna contra el virus del zika. | |
BR112018013387A2 (pt) | vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit | |
EP4233898A3 (en) | Influenza mrna vaccines | |
BR112018009032A8 (pt) | vetor viral de arenavírus infeccioso, composição farmacêutica, composição imunogênica, vacina, método para o tratamento ou a prevenção de infecção pelo vírus da hepatite b em um paciente, uso de um vetor viral, ácido nucleico isolado, vetor viral de arenavírus infeccioso deficiente em replicação e método para sua geração | |
WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
BR112016028816A8 (pt) | combinação imunogênica, método para obter uma resposta imunológica específica, uso de uma combinação imunogênica, e, regime de vacinação para prevenção, redução ou tratamento de infecção por vírus sincicial respiratório | |
TW201613558A (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
MX2023000411A (es) | Vacuna combinada de sars-cov-2 e influenza. | |
MX349119B (es) | Vacuna de virus de dengue inactivado. | |
NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
MX2018006416A (es) | Metodos para el tratamiento, prevencion y diagnostico de infeccion por el virus de la diarrea epidemica porcina. | |
NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
MX2017012389A (es) | Vacuna del virus de la parotiditis recombinante jeryl lynn2. | |
PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
MX2017006744A (es) | Composiciones adyuvantes y metodos relacionados. | |
PH12021550441A1 (en) | Modified pedv spike protein | |
PH12020500414A1 (en) | Method for producing influenza ha split vaccine | |
WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
MX2022006414A (es) | Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar. | |
MX2021004907A (es) | Vacuna de ibv 4/91 con proteina espicular heterologa. | |
MX2021004859A (es) | Vacuna de ibv h52 con proteina espicular heterologa. | |
MX2022004869A (es) | Vacuna de particulas similares al virus chikungunya y metodos de uso de la misma. | |
MX2017014146A (es) | Glicoproteína de hemaglutinina h7 modificada de la secuencia de influenza a/shanghai/2/2013 h7. |